This free Life Sciences Pitch Deck Template from includes 16 editable investor presentation slides structured to help biotech, pharmaceutical, med-tech, and healthcare teams explain clinical value, market opportunity, regulatory direction, and commercialization strategy during fundraising and licensing discussions.
A structured investor communication framework for life sciences companies
- Unmet medical need framing — organised so investors without a clinical background understand the scale and urgency of the treatment gap before your solution is introduced
- Scientific credibility calibrated for a non-specialist audience — mechanism of action, preclinical evidence, and clinical differentiation presented at the depth appropriate for a Series A or Series B investor meeting
- Market and commercial sections arranged in the sequence investors expect — Total Addressable Market, Serviceable Available Market, business model, and revenue projections formatted for fundraising review
- Regulatory and development roadmap structured for any therapeutic area — a visual timeline covering pre-clinical through clinical trial phases, IND submission milestones, and go-to-market strategy, editable for your technology platform and indication.
Slide content across the full investor pitch structure
- Title and executive summary — opens the investor meeting with your company name, one-sentence value proposition, and a snapshot of your development stage and funding objective
- Problem statement and proposed solution — presents current treatment limitations and unmet patient need, then introduces your product or platform with mechanism of action explained for a non-specialist audience
- Market sizing, business model, and competitive landscape — covers addressable market, target patient population, revenue streams, and a comparison of your solution against existing therapies or competing approaches
- Development roadmap and go-to-market strategy — outlines clinical milestones from pre-clinical through Phase II and maps the stages of market entry, formatted for both external investor review and internal planning presentations
- Financial performance and KPI slides — Profit and Loss projections, key growth metrics, and capital allocation structured for fundraising discussions where investors assess commercial viability alongside clinical potential
- Team and advisory board — presents founders, scientific leads, and advisors with individual profiles, built for investor meetings where leadership credibility is part of the funding decision
Who uses this template and when
- Biotech and life sciences founders preparing for Series A or Series B investor meetings — adapt the 16-slide structure to your therapeutic area, development stage, and funding objective without rebuilding from a blank deck.
- Business development and medical affairs teams preparing for licensing partner discussions — the clinical data, market opportunity, and regulatory pathway sections are formatted for audiences evaluating commercial potential alongside scientific merit.
- Healthcare startup teams participating in pitch competitions or incubator programmes — each slide is independently editable so the deck can be restructured to match specific time limits, judging criteria, or investor audience types,
- R&D and strategy teams preparing internal planning presentations — the development roadmap, Financial projections, KPI tracking, and capital allocation slides structured for fundraising discussions where investors evaluate clinical progress alongside commercial viability and operational milestones.
